Variant report
Variant | nsv293285 |
---|---|
Chromosome Location | chr4:165945134-165949254 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | EP300 | chr4:165948914-165949170 | K562 | blood: | n/a | n/a |
2 | JUND | chr4:165948855-165949160 | K562 | blood: | n/a | n/a |
3 | POLR2A | chr4:165945582-165945690 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | POLR2A | chr4:165948511-165948578 | MCF-7 | breast: | n/a | n/a |
5 | RCOR1 | chr4:165948928-165949128 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000250430 | TF binding region |
TRIM60 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs180815724 | chr4:165946621-165946622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs571452699 | chr4:165946626-165946627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553700950 | chr4:165946631-165946632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187418657 | chr4:165946644-165946645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs190665091 | chr4:165946659-165946660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs566338637 | chr4:165946665-165946666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143628091 | chr4:165946678-165946679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555107385 | chr4:165946681-165946682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375809306 | chr4:165946759-165946760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs181921212 | chr4:165946775-165946776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs13112943 | chr4:165946799-165946800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs186169692 | chr4:165946810-165946811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190492560 | chr4:165946858-165946859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558443014 | chr4:165946859-165946860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115546483 | chr4:165946902-165946903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572269435 | chr4:165946930-165946931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542566746 | chr4:165946947-165946948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561089228 | chr4:165946967-165946968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562082527 | chr4:165947001-165947002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549603778 | chr4:165947003-165947004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142366469 | chr4:165947060-165947061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532495452 | chr4:165947079-165947080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547738708 | chr4:165947119-165947120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565952336 | chr4:165947225-165947226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs369976280 | chr4:165947254-165947255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs530374075 | chr4:165947265-165947266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs145931295 | chr4:165947281-165947282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375752341 | chr4:165947299-165947300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570404265 | chr4:165947303-165947304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537627121 | chr4:165947313-165947314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs559223153 | chr4:165947360-165947361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs75863326 | chr4:165947397-165947398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs138517010 | chr4:165947419-165947420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs113307664 | chr4:165947426-165947427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182797689 | chr4:165947432-165947433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544279077 | chr4:165947486-165947487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2056252 | chr4:165947490-165947491 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs571948484 | chr4:165947510-165947511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372983688 | chr4:165947525-165947526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542652542 | chr4:165947550-165947551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs111845781 | chr4:165947554-165947555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376093058 | chr4:165947584-165947585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs556655121 | chr4:165947601-165947602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185617904 | chr4:165947618-165947619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114847033 | chr4:165947726-165947727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543189247 | chr4:165947779-165947780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs564757466 | chr4:165947784-165947785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532433111 | chr4:165947785-165947786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs532170569 | chr4:165947813-165947814 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs541172869 | chr4:165947819-165947820 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
intellectual deficit | 22127048 | CNVD |
abnormal development | 18461090 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:165946600-165947600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr4:165947600-165947800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr4:165947800-165948000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr4:165947800-165948200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr4:165947800-165953200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr4:165948200-165949200 | Enhancers | Brain Cingulate Gyrus | brain |
7 | chr4:165948800-165949600 | Enhancers | Brain Hippocampus Middle | brain |
8 | chr4:165949000-165949400 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr4:165949000-165949600 | Enhancers | Brain Inferior Temporal Lobe | brain |